The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

25 Aug 2015 17:10

RNS Number : 0731X
Oxaco PLC
25 August 2015
 

 

25 August 2015

OXACO PLC

(Formerly OXFORD ADVANCED SURFACES GROUP PLC)

(AIM: OXA)

 

Half Year results for the period ended 30 June 2015

 

OXACO PLC ("the Company") the AIM listed technology developer targeting a number of global markets including automotive, aerospace, electronics and renewable energy announces its half year results for the period ended 30 June 2015.

 

Contacts:

OXACO PLC

www.oxaco.co.uk

James Ede-Golightly, Chairman

T: 01865 854 807

Philip Spinks, Chief Executive Officer Oxford Advanced Surfaces Limited

T: 01865 854 807

WH Ireland Limited

www.wh-ireland.co.uk

John Wakefield

T: 0117 945 3470

 

 

Chairman's statement

 

In conclusion of the measures announced over the last twelve months following a strategic review by the Board, today the Company has announced plans to progress its existing strategic objective of becoming an advanced materials and technology solutions business. It is intended that this will be achieved through the acquisition of Cronin 3D Limited and the demerger of Oxford Advanced Surfaces Limited, details of which can be found in a circular to be published by the Company today.

 

The remainder of the statement provides an update on the progress achieved at Oxford Advanced Surfaces Limited, in which the Company currently holds an interest of approximately 77.54%.

 

 

Strategic Review

Oxford Advanced Surfaces Limited

Oxford Advanced Surfaces Limited ("OAS") continues to make solid progress. The business has now significantly de-risked its technical offering and has delivered a broader range of products to the market that address the preparation and processing issues faced by the users of advanced materials.

 

Everything you use contains materials that need to be prepared and processed and this often requires some form of painting, coating or bonding. There is a global drive for advanced and light-weight materials which deliver excellent bulk properties but present significant preparation and processing challenges. Manufacturers now face a paradigm shift in advanced materials processing - current solutions are often ineffective, time-limited, un-scalable or detrimental to the environment

 

OAS provides unique, effective and simple solutions to the modern preparation and processing challenges that address these issues. Usually just one product from OAS will work on multiple materials and thus reduce the customer's need for a different preparation for each material type.

 

Working closely with our customers we provide technical support and evaluation products to assess the performance of our solutions for preparation and processing problems. Currently we have 32 product evaluations along with a pipeline of 47 additional opportunities. We have also moved three of these evaluations past the technical assessment stage and they are now being assessed either by the commercial team or by the customer's end user.

 

Our focus continues to be on the automotive and industrial markets, however our products are specific to the materials and coatings they are designed for, rather than the end application, so we are also expanding our markets out to aerospace, defence, clean energy and marine - significant growth markets for advanced materials.

 

Since the last report we have launched a new website and also employed a business development executive with significant experience in our target markets. The Board of OAS is now seeking an additional round of funding to support the business through the commercialisation of its products.

 

OntoTM Technology Offering

Onto™ brings a number of benefits to the customer including increased performance, simplified production processes, improved efficiency and sound environmental credentials. We can modify the surface of many hard-to-bond materials in many forms, from particles and fibres through to panels and three dimensional shapes. We are equally effective with small scale off-line processes as we are with high volume in-line manufacturing.

Onto™ products:

· do not damage the surface or impair the bulk properties of the material

· provide consistent results and reduce rejection rates

· can be integrated into existing production processes

· use standard commercial coating and curing equipment

· provide a long usage window

· remove bottle-necks and need for in-line processing

· reduce manual processes and errors

· contain no harmful hydrocarbons

· reduce VOCs in production and consumer use

· are effective on multiple substrates and coatings

The EP1000 and SB1000 series of Onto™ based surface treatments provides manufacturers with versatile coating and bonding solutions for engineering plastics, composites, aluminium, carbon-based materials and other difficult-to-bond substrates. We also offer evaluation products for acrylate inks and coatings (EP2000), as well as a system for the adhesion of metal deposition onto plastic films (EP3000).

Our final product range is for fibre sizing. A composite is the combination of one or more reinforcement agents (e.g. carbon fibre) and a matrix (e.g. epoxy resin). The properties of the final material are usually quite distinct from the original components. A fundamental element of fibre based composites is the bond strength between the fibre and the matrix which usually requires a sizing or adhesion promoter. There are a significant number of sizing solutions for carbon and glass fibre products, but other high-performance materials are less well served and present highly attractive markets for OAS.

Financial Results

Group income for the six month period ended 30 June 2015 was £54,000 (2014: £19,000). This was generated through the sale of evaluation and commercial products of £15,000 (2014: £3,000) along with a further £39,000 (2014: £16,000) from grant funding. The loss before tax for the six month period was £446,000 (2014: £546,000).

 

Research and development costs decreased from £276,000 to £183,000 with Reactive Chemistry costs decreasing from £235,000 to £183,000 and those associated with Particle Technologies reduced from £34,000 to £nil.

 

Interest from deposits for the period amounted to £2,000 (2014: £12,000). This reduction was driven by the lower cash balance and the lack of availability of attractive interest rates in the current financial market.

 

We continue to utilise the benefits from enhanced research and development tax credits and also seek available tax repayments under the Small and Large Company schemes. For the period to 30 June 2015 this credit amounted to £18,000 (2014: £32,000).

 

The Group has £2,139,000 of cash held on instant access of which £1,790,000 remains in the Parent Company.

 

Outlook

The board and management team believe that the revised strategy and long term plans better positions both the PLC and OASL for future success.

We would like to take this opportunity to thank our shareholders for their continued support. We would also like to thank our committed staff who continue to work tirelessly to progress our technology to commercial success.

 

INTERIM CONSOLIDATED INCOME STATEMENT AND STATEMENT OF COMPREHENSIVE INCOME

Unaudited interim consolidated financial statements to 30 June 2015

 

 

 

Six months to

30 June 2015

Six months to

30 June 2014

Year to

31 December 2014

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Continuing Operations

Revenue

15

3

17

Other income - Grants

39

16

69

Total Income

54

19

86

Cost of sales

(41)

(17)

(65)

Research and development costs

(183)

(276)

(494)

Administrative costs

(278)

(284)

(579)

Operating loss

(448)

(558)

(1,052)

Finance income

2

12

15

Loss before tax

(446)

(546)

(1,037)

Income tax credit

18

32

47

Loss and total comprehensive loss for the period

(428)

(514)

(990)

Loss and total comprehensive loss for the period attributable to:

The Company's equity shareholders

(344)

(514)

(939)

Non-controlling interests

(84)

-

(51)

(428)

(514)

(990)

Loss per share attributable to the equity holders of the company:

Total and continuing:

- Basic and diluted (pence)

(0.22)

(0.26)

(0.50)

There were no items of other comprehensive income for the periods covered by these statements and therefore the loss for the year is also the total comprehensive loss for the year net of tax.

 

 

 

INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION

Unaudited interim consolidated financial statements to 30 June 2015

 

 

 

30 June 2015

30 June 2014

31 December 2014

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Assets

Non-current assets

Intangible assets

315

333

319

Plant and equipment

57

123

86

372

456

405

Current assets

Trade and other receivables

106

61

63

Corporation tax recoverable

65

172

47

Short-term investments and cash and cash equivalents

2,139

2,227

2,563

2,310

2,460

2,673

Liabilities

Current liabilities

Trade and other payables

141

136

113

Net Current Assets

2,169

2,324

2,560

Liabilities

Non-current liabilities

Provisions

13

10

13

Net Assets

2,528

2,770

2,952

Shareholders' equity

Called up share capital

1,977

1,977

1,977

Share premium

10,603

10,603

10,603

Merger reserve

6,369

6,369

6,369

Reverse acquisition reserve

(6,831)

(6,831)

(6,831)

Retained earnings

(10,082)

(9,661)

(9,738)

Share-based payments reserve

323

313

319

Total equity attributable to equity holders of the Company

2,359

2,770

2,699

Non-controlling interests

169

-

253

Total Equity

2,528

2,770

2,952

 

 

INTERIM CONSOLIDATED CASH FLOW STATEMENT

Unaudited interim consolidated financial statements to 30 June 2015

 

 

Six months to 30 June 2015

Six months to 30 June 2014

Year to 31 December 2014

Unaudited

Unaudited

Audited

£'000s

£'000s

£'000s

Loss before tax

(446)

(546)

(1,037)

Depreciation and amortisation charges

42

58

112

Impairment of intangible assets

-

-

15

Impairment of property, plant and equipment

-

-

13

Loss/(profit) on disposal of plant and equipment

1

(1)

(5)

Share-based payment expense

4

5

11

Finance income

(2)

(12)

(15)

(401)

(496)

(906)

Increase in trade and other receivables

(44)

(4)

(7)

Increase/(decrease) in trade and other payables

28

16

(4)

Cash outflow from operations

(417)

(484)

(917)

Income tax received

-

-

140

Net cash outflow from operating activities

(417)

(484)

(777)

Cash flows from investing activities

Proceeds from sale of plant and equipment

-

-

5

Purchase of intangible assets

(9)

(30)

(47)

Purchase of plant and equipment

(1)

(31)

(46)

Interest received

3

12

16

Net cash outflow from investing activities

(7)

(49)

(72)

Net cash from financing activities

Issue of shares to non-controlling interests

-

-

652

Net cash inflow from financing activities

-

-

652

Decrease in cash and cash equivalents

(424)

(533)

(197)

Cash and cash equivalents at beginning of year

2,563

2,760

2,760

Cash and cash equivalents at end of year

2,139

2,227

2,563

 

 

Under IAS 7 cash held on long-term deposits that cannot readily be converted into cash has been classified as short term investments. These investments range between three and 12 months.

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

A copy of these interim condensed consolidated financial statements will be available on the Group's website www.oxaco.co.uk 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GMGZRVKKGKZM
Date   Source Headline
5th Jan 20237:00 amRNSCancellation - DEEPMATTER GROUP PLC
4th Jan 20238:00 amRNSHolding(s) in Company
29th Dec 20225:30 pmRNSDeepmatter Group
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20223:44 pmRNSResult of General Meeting
19th Dec 20222:05 pmRNSSecond Price Monitoring Extn
19th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 202211:05 amRNSSecond Price Monitoring Extn
19th Dec 202211:00 amRNSPrice Monitoring Extension
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
9th Dec 202211:05 amRNSSecond Price Monitoring Extn
9th Dec 202211:00 amRNSPrice Monitoring Extension
8th Dec 20228:46 amRNSHolding(s) in Company
2nd Dec 20227:00 amRNSPosting of Circular
1st Dec 20227:00 amRNSProposed Cancellation of Ordinary Shares
24th Nov 20227:00 amRNSCorporate Update
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading Update
26th Oct 20227:00 amRNSDeepMatter signs multi-year license agreement
26th Aug 20221:25 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHalf Year Results
28th Jun 20227:00 amRNSDeepMatter acquires AI specialist ChemIntelligence
20th Jun 20224:41 pmRNSSecond Price Monitoring Extn
20th Jun 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20222:05 pmRNSSecond Price Monitoring Extn
20th Jun 20222:00 pmRNSPrice Monitoring Extension
20th Jun 202211:05 amRNSSecond Price Monitoring Extn
20th Jun 202211:00 amRNSPrice Monitoring Extension
9th Jun 20225:26 pmRNSHolding(s) in Company
27th May 20222:30 pmRNSResult of AGM
25th May 20222:30 pmRNSIssue of Equity and TVR
23rd May 20227:00 amRNSDirectorate Change
20th May 20227:00 amRNSContract extension
11th May 20227:00 amRNSContract
27th Apr 20227:00 amRNSFinal Results
30th Mar 20224:00 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSContract
14th Feb 20227:00 amRNSDirector/PDMR Shareholding
26th Jan 20223:20 pmRNSHolding(s) in Company
26th Jan 20223:15 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSHolding(s) in Company
25th Jan 20225:45 pmRNSHolding(s) in Company
25th Jan 202212:30 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.